T‐cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer
Mehrdad Fathi(Kurdistan University of Medical Sciences), Farhad Jadidi‐Niaragh(Tabriz University of Medical Sciences), Ali Jalili(Kurdistan University of Medical Sciences), Sergey V. Kuznetsov(Sechenov University), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Mars Khayrullin(Moscow State University of Technologies and Management named after K.G. Razumovskiy), Inna Pustokhina(Kazan Federal University), Vahid Karpisheh(Tabriz University of Medical Sciences)
Cited by 51
Related Papers
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
The paradox of Th17 cell functions in tumor immunity
|Cellular Immunology|2017|222
Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
|International Journal of Molecular Sciences|2014|202
A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders
|Molecular Immunology|2018|194